v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Operating activities    
Net income (loss) $ (222,626) $ 76,135
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 180,883 137,851
Amortization of intangible assets 23,061 18,665
Amortization of deferred contract acquisition costs 325,434 227,713
Non-cash operating lease cost 12,625 11,100
Stock-based compensation expense 822,728 592,890
Deferred income taxes (5,362) (2,122)
Realized gains on strategic investments 0 (6,227)
Non-cash interest expense 3,533 2,748
Change in fair value of strategic investments 1,579 0
Accretion of short-term investments purchased at a discount 0 2,285
Changes in operating assets and liabilities, net of impact of acquisitions    
Accounts receivable, net 116,196 39,184
Deferred contract acquisition costs (431,660) (361,412)
Prepaid expenses and other assets (79,440) (42,832)
Accounts payable (9,627) 34,096
Accrued expenses and other liabilities 19,853 85,667
Accrued payroll and benefits 32,607 89,896
Operating lease liabilities (8,979) (11,812)
Deferred revenue 333,675 142,180
Net cash provided by operating activities 1,114,480 1,036,005
Investing activities    
Purchases of property and equipment (199,643) (167,641)
Capitalized internal-use software and website development costs (51,496) (41,266)
Purchases of strategic investments (10,267) (12,702)
Proceeds from sales of strategic investments 4,901 10,895
Business acquisitions, net of cash and restricted cash acquired (380,914) (96,381)
Proceeds from maturities and sales of short-term investments 0 97,300
Purchases of deferred compensation investments (4,257) (1,815)
Proceeds from sales of deferred compensation investments 173 41
Net cash used in investing activities (641,503) (211,569)
Financing activities    
Proceeds from the issuance of common stock upon exercise stock options 2,628 3,308
Proceeds from issuance of common stock under the employee stock purchase plan 74,622 56,099
Distributions to non-controlling interest holders (2,156) (4,085)
Capital contributions from non-controlling interest holders 6,000 5,500
Net cash provided by financing activities 81,094 60,822
Effect of foreign exchange rates on cash, cash equivalents and restricted cash 7,317 (641)
Net increase in cash, cash equivalents and restricted cash 561,388 884,617
Cash, cash equivalents and restricted cash at beginning of period 4,324,666 3,377,597
Cash, cash equivalents and restricted cash at end of period 4,886,054 4,262,214
Cash and cash equivalents 4,801,083 4,260,324
Restricted cash included in prepaid expenses and other current assets 1,011 1,890
Restricted cash included in other long-term assets 83,960 0
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 4,886,054 4,262,214
Supplemental disclosure of cash flow information:    
Interest paid 22,500 22,500
Income taxes paid, net of refunds received 41,505 14,195
Supplemental disclosure of non-cash investing and financing activities:    
Net increase in property and equipment included in accounts payable and accrued expenses 13,744 22,811
Equity consideration for acquisitions 2,302 468
Operating lease liabilities arising from obtaining operating right-of-use assets 35,351 7,009
Proceeds from sales of strategic investments not yet received 166 4,808
Stock-based compensation included in capitalized software development costs and fixed assets 42,493 31,934
Noncash consideration for the purchase of strategic investments 1,101 3,319
Noncash consideration received from sales of strategic investments 0 3,319
Fair value of common stock issued for consideration transferred 10,318 0
Restricted cash held in escrow for purchase consideration for business combinations $ 83,000 $ 0